A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cabozantinib
Related studies linked through entity extraction aliases.
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Cabozantinib for Adults With Advanced Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Cabozantinib for Metastatic Triple Negative BrCa
- Status
- COMPLETED
- Phase
- PHASE2
Cabozantinib in Men With Castration-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib for Advanced Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Expanded Access of Cabozantinib in Medullary Thyroid Cancer
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- Status
- RECRUITING
- Phase
- PHASE2
Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
- Status
- COMPLETED
- Phase
- PHASE3
Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cabozantinib in Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
- Status
- COMPLETED
- Phase
- PHASE1
XL-184+Abiraterone in Post-Chemo CRPC
- Status
- COMPLETED
- Phase
- PHASE1
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Study to Assess the Pharmacokinetics of Cabozantinib (XL184) in Hepatic Impaired Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
- Status
- COMPLETED
- Phase
- PHASE2